Lexeo Therapeutics (LXEO) Income Statement (2022 - 2026)
Income Statement report data from Mar 31, 2022 to Mar 31, 2026 for Lexeo Therapeutics (LXEO).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 120K (-77.36%) | 530K | - | - |
Operating Expenses | |||||||||||||||||
Research And Development | 16M | - | 16M (+6.66%) | 15M (-14.27%) | 17M (-6.53%) | 18M (-21.56%) | 23M (+41.43%) | 17M (+5.21%) | 16M (+91.72%) | 8.21M (-52.41%) | 17M (+53.47%) | 11M (-31.63%) | 16M (-51.36%) | 34M (+120.05%) | 15M | - | - |
Selling General And Administrative | 6.63M | - | 5.95M (-62.74%) | 16M (-3.97%) | 17M (+84.37%) | 9.02M (+11.08%) | 8.12M (+16.17%) | 6.99M (-7.42%) | 7.55M (+11.52%) | 6.77M (+123.43%) | 3.03M (+10.58%) | 2.74M (-3.86%) | 2.85M (-69.52%) | 9.35M (+252.83%) | 2.65M | - | - |
Operating Expenses | 22M | - | 22M (-29.46%) | 31M (-9.23%) | 34M (+23.48%) | 27M (-13.19%) | 32M (+33.93%) | 24M (+1.12%) | 23M (+55.47%) | 15M (-26.10%) | 20M (+44.99%) | 14M (-27.53%) | 19M (-55.30%) | 43M (+139.59%) | 18M | - | - |
Depreciation And Amortization | 70K | - | - | - | 60K (-75.00%) | 240K | - | - | 70K (-66.67%) | 210K | - | - | 60K (-50.00%) | 120K | - | - | - |
Operating Income | |||||||||||||||||
Operating Income | -22.33M | - | -21.65M (-29.46%) | -30.69M (-9.20%) | -33.80M (+23.45%) | -27.38M (-13.19%) | -31.54M (+33.93%) | -23.55M (+1.12%) | -23.29M (+55.58%) | -14.97M (-26.15%) | -20.27M (+45.10%) | -13.97M (-27.58%) | -19.29M (-55.17%) | -43.03M (+146.17%) | -17.48M | - | - |
Ebit | -22.33M (-77.67%) | -100.00M (+361.89%) | -21.65M (-29.46%) | -30.69M (-9.20%) | -33.80M (+23.45%) | -27.38M (-13.19%) | -31.54M (+33.93%) | -23.55M (+1.12%) | -23.29M (+55.58%) | -14.97M (-26.15%) | -20.27M (+45.10%) | -13.97M (-27.58%) | -19.29M (+25.42%) | -15.38M (-12.01%) | -17.48M (+15.46%) | -15.14M (+21.12%) | -12.50M |
EBITDA | -22.26M (-77.74%) | -100.00M (+393.58%) | -20.26M (-22.32%) | -26.08M (-22.70%) | -33.74M (+6.84%) | -31.58M (+7.23%) | -29.45M (+38.92%) | -21.20M (-8.70%) | -23.22M (+49.23%) | -15.56M (-22.43%) | -20.06M (+49.81%) | -13.39M (-30.37%) | -19.23M (+22.33%) | -15.72M (-7.69%) | -17.03M (+12.48%) | -15.14M (+21.12%) | -12.50M |
Other Income / Expenses | |||||||||||||||||
Interest Income | 2.11M | - | 1.46M (+14.96%) | 1.27M (+6.72%) | 1.19M (-19.05%) | 1.47M (-29.67%) | 2.09M (-11.06%) | 2.35M (+42.42%) | 1.65M (+50.00%) | 1.10M (+124.49%) | 490K (-16.95%) | 590K (-14.49%) | 690K (-20.69%) | 870K (+89.13%) | 460K | - | - |
Interest Expense | 20K | - | 20K (-33.33%) | 30K (0.00%) | 30K (0.00%) | 30K (-25.00%) | 40K (0.00%) | 40K (0.00%) | 40K (-20.00%) | 50K (0.00%) | 50K (0.00%) | 50K (0.00%) | 50K (-16.67%) | 60K (+100.00%) | 30K | - | - |
Net Interest Income | 2.11M | - | 1.46M (+14.96%) | 1.27M (+6.72%) | 1.19M (-22.73%) | 1.54M (-26.32%) | 2.09M (-9.52%) | 2.31M (+43.48%) | 1.61M (+53.33%) | 1.05M (+138.64%) | 440K (-18.52%) | 540K (-15.63%) | 640K (-20.99%) | 810K (+88.37%) | 430K | - | - |
Other Non Operating Income | - | - | -10.00K (0.00%) | -10.00K | - | -10.00K | - | - | - | -10.00K | - | - | - | - | 430K | - | - |
Net Income | |||||||||||||||||
Income Before Tax | -20.20M | - | -20.28M (-22.30%) | -26.10M (-20.09%) | -32.66M (+25.47%) | -26.03M (-11.73%) | -29.49M (+38.84%) | -21.24M (-2.03%) | -21.68M (+52.78%) | -14.19M (-29.44%) | -20.11M (+49.63%) | -13.44M (-27.97%) | -18.66M (-55.80%) | -42.22M (+147.62%) | -17.05M | - | - |
Net Income From Continuing Operations | -20.20M (-79.80%) | -100.00M (+393.10%) | -20.28M (-22.30%) | -26.10M (-20.09%) | -32.66M (+26.00%) | -25.92M (-12.11%) | -29.49M (+38.84%) | -21.24M (-2.03%) | -21.68M (+52.78%) | -14.19M (-29.44%) | -20.11M (+49.63%) | -13.44M (-27.97%) | -18.66M (+27.98%) | -14.58M (-14.49%) | -17.05M (+12.62%) | -15.14M (+21.12%) | -12.50M |
Net Income | -20.20M (-79.80%) | -100.00M (+393.10%) | -20.28M (-22.30%) | -26.10M (-20.09%) | -32.66M (+26.00%) | -25.92M (-12.11%) | -29.49M (+38.84%) | -21.24M (-2.03%) | -21.68M (+52.78%) | -14.19M (-29.44%) | -20.11M (+49.63%) | -13.44M (-27.97%) | -18.66M (+27.98%) | -14.58M (-14.49%) | -17.05M (+12.62%) | -15.14M (+21.12%) | -12.50M |
Comprehensive Income Net Of Tax | -20.53M | - | -20.18M (-22.56%) | -26.06M (-20.09%) | -32.61M (-66.87%) | -98.44M (+233.81%) | -29.49M (+38.84%) | -21.24M (-2.03%) | -21.68M (-67.34%) | -66.39M | - | - | - | - | - | - | - |